Literature DB >> 20134017

Transmission potential of two chimeric western equine encephalitis vaccine candidates in Culex tarsalis.

Joan L Kenney1, A Paige Adams, Scott C Weaver.   

Abstract

Western equine encephalitis virus (WEEV) is a zoonotic alphavirus that circulates in western North America between passerine birds and mosquitoes, primarily Culex tarsalis. Since it was isolated in 1930, WEEV has caused tens of thousands of equine deaths in addition to thousands of human cases. In addition because WEEV is a virus of agricultural importance in addition to a public health threat, we developed two live-attenuated chimeric vaccine candidates that have been shown to be immunogenic and efficacious in mouse models. Vaccine candidate strains were developed by inserting the structural protein genes of WEEV strain McMillan (McM) or CO92-1356 into a Sindbis virus (SINV) strain AR339 backbone. The SIN/McM chimera also derived the N-terminal half of its capsid gene from a North American eastern equine encephalitis virus (EEEV) strain FL39-939 (henceforth referred to as SIN/EEE/McM). Although these vaccines do not generate viremia in mice, we further assessed their safety by exposing Cx. tarsalis to artificial blood meals containing high viral titers of each vaccine candidate. Both viruses exhibited a decreased rate of infection, dissemination, and transmission potential compared with the parental alphaviruses. Specifically, SIN/CO92 infected 37% of mosquitoes and disseminated in 8%, but failed to reach the saliva of the mosquitoes. In contrast, the SIN/EEE/McM virus was unable to infect, disseminate, or be transmitted in the saliva of any mosquitoes. These findings suggest that both vaccine candidates are less competent than the parental strains to be transmitted by the primary mosquito vector, Cx. tarsalis, and are unlikely to be reintroduced into a natural WEEV transmission cycle.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20134017      PMCID: PMC2813181          DOI: 10.4269/ajtmh.2010.09-0092

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Vector relationships of the arthropod-borne encephalitides in North America.

Authors:  R W CHAMBERLAIN
Journal:  Ann N Y Acad Sci       Date:  1958-06-03       Impact factor: 5.691

2.  Dual host infections: enhanced infectivity of eastern equine encephalitis virus to Aedes mosquitoes mediated by Brugia microfilariae.

Authors:  J A Vaughan; M J Turell
Journal:  Am J Trop Med Hyg       Date:  1996-01       Impact factor: 2.345

3.  Mosquito Vectors and Inapparent Animal Reservoirs of St. Louis and Western Equine Encephalitis Viruses.

Authors:  W M Hammon; W C Reeves; M Gray
Journal:  Am J Public Health Nations Health       Date:  1943-03

Review 4.  Seasonal dynamics of western encephalitis virus.

Authors:  A D Hess; R O Hayes
Journal:  Am J Med Sci       Date:  1967-03       Impact factor: 2.378

5.  The ecology of western equine encephalomyelitis virus in the Central Valley of California, 1945-1985.

Authors:  J L Hardy
Journal:  Am J Trop Med Hyg       Date:  1987-11       Impact factor: 2.345

6.  An assessment of the biological capacity of a Sacramento Valley population of Aedes melanimon to vector arboviruses.

Authors:  T Jensen; R K Washino
Journal:  Am J Trop Med Hyg       Date:  1991-04       Impact factor: 2.345

7.  Recombinational history and molecular evolution of western equine encephalomyelitis complex alphaviruses.

Authors:  S C Weaver; W Kang; Y Shirako; T Rumenapf; E G Strauss; J H Strauss
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus.

Authors:  Patricia V Aguilar; Slobodan Paessler; Anne-Sophie Carrara; Samuel Baron; Joyce Poast; Eryu Wang; Abelardo C Moncayo; Michael Anishchenko; Douglas Watts; Robert B Tesh; Scott C Weaver
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus.

Authors:  Svetlana Atasheva; Eryu Wang; A Paige Adams; Kenneth S Plante; Sai Ni; Katherine Taylor; Mary E Miller; Ilya Frolov; Scott C Weaver
Journal:  Vaccine       Date:  2009-05-27       Impact factor: 3.641

10.  Ecology of Aedes dorsalis (Diptera: Culicidae) in relation to western equine encephalomyelitis virus in the Coachella Valley of California.

Authors:  W K Reisen; H D Lothrop; R E Chiles
Journal:  J Med Entomol       Date:  1998-07       Impact factor: 2.278

View more
  6 in total

1.  Transmission potential of two chimeric Chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus.

Authors:  Justin R Darwin; Joan L Kenney; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

2.  Emergence of zoonotic arboviruses by animal trade and migration.

Authors:  Martin Pfeffer; Gerhard Dobler
Journal:  Parasit Vectors       Date:  2010-04-08       Impact factor: 3.876

3.  Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus.

Authors:  Svetlana Atasheva; Eryu Wang; A Paige Adams; Kenneth S Plante; Sai Ni; Katherine Taylor; Mary E Miller; Ilya Frolov; Scott C Weaver
Journal:  Vaccine       Date:  2009-05-27       Impact factor: 3.641

4.  Infection, Dissemination, and Transmission Potential of North American Culex quinquefasciatus, Culex tarsalis, and Culicoides sonorensis for Oropouche Virus.

Authors:  Bethany L McGregor; C Roxanne Connelly; Joan L Kenney
Journal:  Viruses       Date:  2021-02-02       Impact factor: 5.048

5.  Identification of salivary gland escape barriers to western equine encephalitis virus in the natural vector, Culex tarsalis.

Authors:  Charles B Stauft; Aaron T Phillips; Tony T Wang; Kenneth E Olson
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

Review 6.  A molecular understanding of alphavirus entry.

Authors:  Autumn C Holmes; Katherine Basore; Daved H Fremont; Michael S Diamond
Journal:  PLoS Pathog       Date:  2020-10-22       Impact factor: 7.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.